PERK signaling, which is activated downstream of the UPR and the integrated stress response (ISR), is triggered in response to a range of pathophysiological changes, and enables cancer cells to survive the adverse conditions typically observed in the tumor microenvironment. Here, EIF2AK3 is linked to neoplasm.